
Brain UK study ref: 25/015
Lay summary
Project status: Active
Investigating inflammatory pathways in mitochondrial disease
Prof Johnson and Dr Olkhova, Northumbria University
Mitochondrial diseases are rare disorders that affect the energy-generating “batteries” of the cell. Patients may suffer from cognitive decline, movement disorder, seizures. There are no therapies for mitochondrial diseases. We showed that in a mouse model of mitochondrial disease, there is infiltration of immune cells in the brain regions affected. If you wipe out these immune cells, disease and neuronal death in the brain is prevented fully. We want to validate these findings in human brain tissues donated by patients. Hence, in this project we will use microscopy and staining to look at immune markers in the brain to check for inflammation. This would inform us whether similar immune activation exists in human condition as it does in mice. There are licensed drugs and antibodies available to deplete these immune cells and small inflammatory chemicals they produce to cause an even greater infiltration of immune cells to the vulnerable brain areas, with potential to ameliorate the disease.
